BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22192801)

  • 21. Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
    Yassin Fel-Z
    Pathol Res Pract; 2016 May; 212(5):398-409. PubMed ID: 26907783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A combined biomarker pattern improves the discrimination of lung cancer.
    Liu L; Liu J; Wang Y; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
    Biomarkers; 2011 Feb; 16(1):20-30. PubMed ID: 20964562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.
    Wang X; Han J; Hardie DB; Yang J; Borchers CH
    J Mass Spectrom; 2016 Jan; 51(1):86-95. PubMed ID: 26757076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Amann JM; Chaurand P; Gonzalez A; Mobley JA; Massion PP; Carbone DP; Caprioli RM
    Clin Cancer Res; 2006 Sep; 12(17):5142-50. PubMed ID: 16951232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
    Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
    Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.
    Elsner M; Rauser S; Maier S; Schöne C; Balluff B; Meding S; Jung G; Nipp M; Sarioglu H; Maccarrone G; Aichler M; Feuchtinger A; Langer R; Jütting U; Feith M; Küster B; Ueffing M; Zitzelsberger H; Höfler H; Walch A
    J Proteomics; 2012 Aug; 75(15):4693-704. PubMed ID: 22365974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markers.
    Rathinam S; Ward DG; James ND; Rajesh PB
    Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):3-6. PubMed ID: 21525028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic patterns of tumour subsets in non-small-cell lung cancer.
    Yanagisawa K; Shyr Y; Xu BJ; Massion PP; Larsen PH; White BC; Roberts JR; Edgerton M; Gonzalez A; Nadaf S; Moore JH; Caprioli RM; Carbone DP
    Lancet; 2003 Aug; 362(9382):433-9. PubMed ID: 12927430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer.
    Feng XL; Li L; Gao YN; Zhang JJ; Xiao T; Ying JM; Gao JD; Sun YT; Cheng SJ
    Med Oncol; 2011 Mar; 28(1):336-41. PubMed ID: 20237870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preliminary analysis of non-small cell lung cancer biomarkers in serum.
    Xiao XY; Tang Y; Wei XP; He DC
    Biomed Environ Sci; 2003 Jun; 16(2):140-8. PubMed ID: 12964787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The study of differential proteins in patients with peripheral lung cancer by surface-enhanced laser desorption/ionization time of flight mass technology].
    Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jan; 34(1):30-3. PubMed ID: 21429416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
    Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling--a pilot study.
    Remmerbach TW; Maurer K; Janke S; Schellenberger W; Eschrich K; Bertolini J; Hofmann H; Rupf S
    Oral Oncol; 2011 Apr; 47(4):278-81. PubMed ID: 21354855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
    Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
    PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced transthyretin expression in sera of lung cancer.
    Liu L; Liu J; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
    Cancer Sci; 2007 Oct; 98(10):1617-24. PubMed ID: 17683510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis.
    Tian T; Hao J; Xu A; Hao J; Luo C; Liu C; Huang L; Xiao X; He D
    Cancer Sci; 2007 Aug; 98(8):1265-74. PubMed ID: 17537172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.
    Balluff B; Rauser S; Meding S; Elsner M; Schöne C; Feuchtinger A; Schuhmacher C; Novotny A; Jütting U; Maccarrone G; Sarioglu H; Ueffing M; Braselmann H; Zitzelsberger H; Schmid RM; Höfler H; Ebert MP; Walch A
    Am J Pathol; 2011 Dec; 179(6):2720-9. PubMed ID: 22015459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
    Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
    Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging.
    Bensussan AV; Lin J; Guo C; Katz R; Krishnamurthy S; Cressman E; Eberlin LS
    Clin Chem; 2020 Nov; 66(11):1424-1433. PubMed ID: 33141910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.